PT  - JOURNAL ARTICLE
AU  - Sinclair, Heather Q.
ED  - Connolly, Stuart J.
TI  - Apixaban Reduces Stroke Risk in Patients with AF: Results from the AVERROES Trial
DP  - 2010 Dec 01
TA  - MD Conference Express
PG  - 14--14
VI  - 10
IP  - 8
4099  - http://mdc.sagepub.com/content/10/8/14.short
4100  - http://mdc.sagepub.com/content/10/8/14.full
AB  - The oral direct factor Xa inhibitor apixaban was superior to aspirin therapy for the reduction of stroke or systemic embolism risk in patients with atrial fibrillation who were unsuitable for vitamin K antagonist therapy according to the phase III Apixaban versus Acetylsalicylic Acid to Prevent Strokes [AVERROES; NCT00496769] trial.